Clinical trial
Combination Chemotherapy in Treating Children With Refractory or Relapsed…
NCT00006760 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00006760 |
|---|---|
| Title | Combination Chemotherapy in Treating Children With Refractory or Relapsed Hodgkin's Lymphoma |
| Official title | A Pilot Study of Re-Induction Chemotherapy With Ifosfamide, and Vinorelbine (IV) in Children With Refractory/Relapsed Hodgkin's Disease |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Biological, Drug |
| Interventions | filgrastim, ifosfamide, vinorelbine tartrate |
| Enrollment | 66 |
| Start date | May 1, 2001 |
| Primary completion | Jul 1, 2005 |
| Completion | Mar 1, 2012 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 26, 2013 |
| Countries | Australia, Canada, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: